The global market for Enzyme-Linked Immunosorbent Assay (Elisa) Testing was estimated to be worth US$ 179 million in 2023 and is forecast to a readjusted size of US$ 230.5 million by 2030 with a CAGR of 3.6% during the forecast period 2024-2030

Enzyme-Linked Immunosorbent Assay (Elisa) Testing - Market

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.

Global Enzyme-Linked Immunosorbent Assay (ELISA) key players include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, etc. Global top four manufacturers hold a share over 45%.

China is the largest market, with a share over 35%, followed by Europe, and USA, both have a share over 30 percent.

In terms of product, Indirect ELISA is the largest segment, with a share over 45%. And in terms of application, the largest application is Immunology, followed by Infectious Diseases, Protein Quantitation, Cancer, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enzyme-Linked Immunosorbent Assay (Elisa) Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Enzyme-Linked Immunosorbent Assay (Elisa) Testing by region & country, by Type, and by Application.

The Enzyme-Linked Immunosorbent Assay (Elisa) Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme-Linked Immunosorbent Assay (Elisa) Testing.

Market Segmentation

Scope of Enzyme-Linked Immunosorbent Assay (Elisa) Testing - Market Report

Report Metric	Details
Report Name	Enzyme-Linked Immunosorbent Assay (Elisa) Testing - Market
Forecasted market size in 2030	US$ 230.5 million
CAGR	3.6%
Forecasted years	2024 - 2030
Segment by Type:	Sandwich ELISA Indirect ELISA Multiple and portable ELISA Competitive ELISA
Segment by Application	Immunology Inflammation Infectious diseases Cancer Protein quantitation Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ortho-Clinical Diagnostics, Inc., Thermo Fisher Scientific. Inc., Life Technologies Corporation, ZEUS Scientific, Inc., R & D Systems (a Biotechne brand), Abbexa, Abcam, Abelisa, Abnova, Bhat Bio-tech, Bio-Rad Laboratories, Biorbyt, Calbiotech, Cayman Chemicals, Crystal Chem, Diagenics, Eagle Biosciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Enzyme-Linked Immunosorbent Assay (Elisa) Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Enzyme-Linked Immunosorbent Assay (Elisa) Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Enzyme-Linked Immunosorbent Assay (Elisa) Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Enzyme-Linked Immunosorbent Assay (Elisa) Testing - Market size in 2030?

Ans: The Enzyme-Linked Immunosorbent Assay (Elisa) Testing - Market size in 2030 will be US$ 230.5 million.

What is the market share of major companies in Enzyme-Linked Immunosorbent Assay (Elisa) Testing - Market?

Ans: Global top four manufacturers hold a share over 45%.

What is the Enzyme-Linked Immunosorbent Assay (Elisa) Testing - Market share by type?

Ans: In terms of product, Indirect ELISA is the largest segment, with a share over 45%.

Who are the main players in the Enzyme-Linked Immunosorbent Assay (Elisa) Testing - Market report?

Ans: The main players in the Enzyme-Linked Immunosorbent Assay (Elisa) Testing - Market are Ortho-Clinical Diagnostics, Inc., Thermo Fisher Scientific. Inc., Life Technologies Corporation, ZEUS Scientific, Inc., R & D Systems (a Biotechne brand), Abbexa, Abcam, Abelisa, Abnova, Bhat Bio-tech, Bio-Rad Laboratories, Biorbyt, Calbiotech, Cayman Chemicals, Crystal Chem, Diagenics, Eagle Biosciences

What are the Application segmentation covered in the Enzyme-Linked Immunosorbent Assay (Elisa) Testing - Market report?

Ans: The Applications covered in the Enzyme-Linked Immunosorbent Assay (Elisa) Testing - Market report are Immunology, Inflammation, Infectious diseases, Cancer, Protein quantitation, Other

What are the Type segmentation covered in the Enzyme-Linked Immunosorbent Assay (Elisa) Testing - Market report?

Ans: The Types covered in the Enzyme-Linked Immunosorbent Assay (Elisa) Testing - Market report are Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, Competitive ELISA

1 Market Overview

1.1 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Product Introduction

1.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Size Forecast

1.3 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Trends & Drivers

1.3.1 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Industry Trends

1.3.2 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Drivers & Opportunity

1.3.3 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Challenges

1.3.4 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Players Revenue Ranking (2023)

2.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue by Company (2019-2024)

2.3 Key Companies Enzyme-Linked Immunosorbent Assay (Elisa) Testing Manufacturing Base Distribution and Headquarters

2.4 Key Companies Enzyme-Linked Immunosorbent Assay (Elisa) Testing Product Offered

2.5 Key Companies Time to Begin Mass Production of Enzyme-Linked Immunosorbent Assay (Elisa) Testing

2.6 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Competitive Analysis

2.6.1 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Sandwich ELISA

3.1.2 Indirect ELISA

3.1.3 Multiple and portable ELISA

3.1.4 Competitive ELISA

3.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type

3.2.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, by Type (2019-2030)

3.2.3 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Immunology

4.1.2 Inflammation

4.1.3 Infectious diseases

4.1.4 Cancer

4.1.5 Protein quantitation

4.1.6 Other

4.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application

4.2.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, by Application (2019-2030)

4.2.3 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Region

5.1.1 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Region (2019-2024)

5.1.3 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Region (2025-2030)

5.1.4 Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030

5.2.2 North America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030

5.3.2 Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030

5.4.2 Asia Pacific Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030

5.5.2 South America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030

5.6.2 Middle East & Africa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value

6.3 United States

6.3.1 United States Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030

6.3.2 United States Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030

6.4.2 Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030

6.5.2 China Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030

6.5.3 China Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030

6.6.2 Japan Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030

6.7.2 South Korea Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030

6.8.2 Southeast Asia Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019-2030

6.9.2 India Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030

6.9.3 India Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Ortho-Clinical Diagnostics, Inc.

7.1.1 Ortho-Clinical Diagnostics, Inc. Profile

7.1.2 Ortho-Clinical Diagnostics, Inc. Main Business

7.1.3 Ortho-Clinical Diagnostics, Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.1.4 Ortho-Clinical Diagnostics, Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.1.5 Ortho-Clinical Diagnostics, Inc. Recent Developments

7.2 Thermo Fisher Scientific. Inc.

7.2.1 Thermo Fisher Scientific. Inc. Profile

7.2.2 Thermo Fisher Scientific. Inc. Main Business

7.2.3 Thermo Fisher Scientific. Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.2.4 Thermo Fisher Scientific. Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.2.5 Thermo Fisher Scientific. Inc. Recent Developments

7.3 Life Technologies Corporation

7.3.1 Life Technologies Corporation Profile

7.3.2 Life Technologies Corporation Main Business

7.3.3 Life Technologies Corporation Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.3.4 Life Technologies Corporation Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.3.5 ZEUS Scientific, Inc. Recent Developments

7.4 ZEUS Scientific, Inc.

7.4.1 ZEUS Scientific, Inc. Profile

7.4.2 ZEUS Scientific, Inc. Main Business

7.4.3 ZEUS Scientific, Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.4.4 ZEUS Scientific, Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.4.5 ZEUS Scientific, Inc. Recent Developments

7.5 R & D Systems (a Biotechne brand)

7.5.1 R & D Systems (a Biotechne brand) Profile

7.5.2 R & D Systems (a Biotechne brand) Main Business

7.5.3 R & D Systems (a Biotechne brand) Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.5.4 R & D Systems (a Biotechne brand) Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.5.5 R & D Systems (a Biotechne brand) Recent Developments

7.6 Abbexa

7.6.1 Abbexa Profile

7.6.2 Abbexa Main Business

7.6.3 Abbexa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.6.4 Abbexa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.6.5 Abbexa Recent Developments

7.7 Abcam

7.7.1 Abcam Profile

7.7.2 Abcam Main Business

7.7.3 Abcam Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.7.4 Abcam Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.7.5 Abcam Recent Developments

7.8 Abelisa

7.8.1 Abelisa Profile

7.8.2 Abelisa Main Business

7.8.3 Abelisa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.8.4 Abelisa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.8.5 Abelisa Recent Developments

7.9 Abnova

7.9.1 Abnova Profile

7.9.2 Abnova Main Business

7.9.3 Abnova Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.9.4 Abnova Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.9.5 Abnova Recent Developments

7.10 Bhat Bio-tech

7.10.1 Bhat Bio-tech Profile

7.10.2 Bhat Bio-tech Main Business

7.10.3 Bhat Bio-tech Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.10.4 Bhat Bio-tech Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.10.5 Bhat Bio-tech Recent Developments

7.11 Bio-Rad Laboratories

7.11.1 Bio-Rad Laboratories Profile

7.11.2 Bio-Rad Laboratories Main Business

7.11.3 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.11.4 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.11.5 Bio-Rad Laboratories Recent Developments

7.12 Biorbyt

7.12.1 Biorbyt Profile

7.12.2 Biorbyt Main Business

7.12.3 Biorbyt Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.12.4 Biorbyt Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.12.5 Biorbyt Recent Developments

7.13 Calbiotech

7.13.1 Calbiotech Profile

7.13.2 Calbiotech Main Business

7.13.3 Calbiotech Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.13.4 Calbiotech Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.13.5 Calbiotech Recent Developments

7.14 Cayman Chemicals

7.14.1 Cayman Chemicals Profile

7.14.2 Cayman Chemicals Main Business

7.14.3 Cayman Chemicals Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.14.4 Cayman Chemicals Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.14.5 Cayman Chemicals Recent Developments

7.15 Crystal Chem

7.15.1 Crystal Chem Profile

7.15.2 Crystal Chem Main Business

7.15.3 Crystal Chem Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.15.4 Crystal Chem Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.15.5 Crystal Chem Recent Developments

7.16 Diagenics

7.16.1 Diagenics Profile

7.16.2 Diagenics Main Business

7.16.3 Diagenics Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.16.4 Diagenics Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.16.5 Diagenics Recent Developments

7.17 Eagle Biosciences

7.17.1 Eagle Biosciences Profile

7.17.2 Eagle Biosciences Main Business

7.17.3 Eagle Biosciences Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

7.17.4 Eagle Biosciences Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue (US$ Million) & (2019-2024)

7.17.5 Eagle Biosciences Recent Developments

8 Industry Chain Analysis

8.1 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Industrial Chain

8.2 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Model

8.5.2 Sales Channel

8.5.3 Enzyme-Linked Immunosorbent Assay (Elisa) Testing Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Abcam

Bio Rad Laboratories

Ortho Clinical Diagnostics Inc

Thermo Fisher Scientific Inc

Life Technologies Corporation

Zeus Scientific, Inc.

R & D Systems (a Biotechne brand)

List of Tables

Table 1. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Trends

Table 2. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Drivers & Opportunity

Table 3. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Challenges

Table 4. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Restraints

Table 5. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Enzyme-Linked Immunosorbent Assay (Elisa) Testing Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Enzyme-Linked Immunosorbent Assay (Elisa) Testing Product Type

Table 9. Key Companies Time to Begin Mass Production of Enzyme-Linked Immunosorbent Assay (Elisa) Testing

Table 10. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzyme-Linked Immunosorbent Assay (Elisa) Testing as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Region (2019-2024) & (%)

Table 27. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, (2025-2030) & (US$ Million)

Table 31. Ortho-Clinical Diagnostics, Inc. Basic Information List

Table 32. Ortho-Clinical Diagnostics, Inc. Description and Business Overview

Table 33. Ortho-Clinical Diagnostics, Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 34. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of Ortho-Clinical Diagnostics, Inc. (2019-2024)

Table 35. Ortho-Clinical Diagnostics, Inc. Recent Developments

Table 36. Thermo Fisher Scientific. Inc. Basic Information List

Table 37. Thermo Fisher Scientific. Inc. Description and Business Overview

Table 38. Thermo Fisher Scientific. Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 39. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of Thermo Fisher Scientific. Inc. (2019-2024)

Table 40. Thermo Fisher Scientific. Inc. Recent Developments

Table 41. Life Technologies Corporation Basic Information List

Table 42. Life Technologies Corporation Description and Business Overview

Table 43. Life Technologies Corporation Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 44. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of Life Technologies Corporation (2019-2024)

Table 45. Life Technologies Corporation Recent Developments

Table 46. ZEUS Scientific, Inc. Basic Information List

Table 47. ZEUS Scientific, Inc. Description and Business Overview

Table 48. ZEUS Scientific, Inc. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 49. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of ZEUS Scientific, Inc. (2019-2024)

Table 50. ZEUS Scientific, Inc. Recent Developments

Table 51. R & D Systems (a Biotechne brand) Basic Information List

Table 52. R & D Systems (a Biotechne brand) Description and Business Overview

Table 53. R & D Systems (a Biotechne brand) Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 54. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of R & D Systems (a Biotechne brand) (2019-2024)

Table 55. R & D Systems (a Biotechne brand) Recent Developments

Table 56. Abbexa Basic Information List

Table 57. Abbexa Description and Business Overview

Table 58. Abbexa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 59. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of Abbexa (2019-2024)

Table 60. Abbexa Recent Developments

Table 61. Abcam Basic Information List

Table 62. Abcam Description and Business Overview

Table 63. Abcam Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 64. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of Abcam (2019-2024)

Table 65. Abcam Recent Developments

Table 66. Abelisa Basic Information List

Table 67. Abelisa Description and Business Overview

Table 68. Abelisa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 69. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of Abelisa (2019-2024)

Table 70. Abelisa Recent Developments

Table 71. Abnova Basic Information List

Table 72. Abnova Description and Business Overview

Table 73. Abnova Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 74. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of Abnova (2019-2024)

Table 75. Abnova Recent Developments

Table 76. Bhat Bio-tech Basic Information List

Table 77. Bhat Bio-tech Description and Business Overview

Table 78. Bhat Bio-tech Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 79. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of Bhat Bio-tech (2019-2024)

Table 80. Bhat Bio-tech Recent Developments

Table 81. Bio-Rad Laboratories Basic Information List

Table 82. Bio-Rad Laboratories Description and Business Overview

Table 83. Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 84. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of Bio-Rad Laboratories (2019-2024)

Table 85. Bio-Rad Laboratories Recent Developments

Table 86. Biorbyt Basic Information List

Table 87. Biorbyt Description and Business Overview

Table 88. Biorbyt Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 89. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of Biorbyt (2019-2024)

Table 90. Biorbyt Recent Developments

Table 91. Calbiotech Basic Information List

Table 92. Calbiotech Description and Business Overview

Table 93. Calbiotech Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 94. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of Calbiotech (2019-2024)

Table 95. Calbiotech Recent Developments

Table 96. Cayman Chemicals Basic Information List

Table 97. Cayman Chemicals Description and Business Overview

Table 98. Cayman Chemicals Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 99. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of Cayman Chemicals (2019-2024)

Table 100. Cayman Chemicals Recent Developments

Table 101. Crystal Chem Basic Information List

Table 102. Crystal Chem Description and Business Overview

Table 103. Crystal Chem Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 104. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of Crystal Chem (2019-2024)

Table 105. Crystal Chem Recent Developments

Table 106. Diagenics Basic Information List

Table 107. Diagenics Description and Business Overview

Table 108. Diagenics Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 109. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of Diagenics (2019-2024)

Table 110. Diagenics Recent Developments

Table 111. Eagle Biosciences Basic Information List

Table 112. Eagle Biosciences Description and Business Overview

Table 113. Eagle Biosciences Enzyme-Linked Immunosorbent Assay (Elisa) Testing Products, Services and Solutions

Table 114. Revenue (US$ Million) in Enzyme-Linked Immunosorbent Assay (Elisa) Testing Business of Eagle Biosciences (2019-2024)

Table 115. Eagle Biosciences Recent Developments

Table 116. Key Raw Materials Lists

Table 117. Raw Materials Key Suppliers Lists

Table 118. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Downstream Customers

Table 119. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Distributors List

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

Table 123. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Product Picture

Figure 2. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value (2019-2030) & (US$ Million)

Figure 4. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Report Years Considered

Figure 5. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Enzyme-Linked Immunosorbent Assay (Elisa) Testing Revenue in 2023

Figure 7. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Sandwich ELISA Picture

Figure 9. Indirect ELISA Picture

Figure 10. Multiple and portable ELISA Picture

Figure 11. Competitive ELISA Picture

Figure 12. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of Immunology

Figure 15. Product Picture of Inflammation

Figure 16. Product Picture of Infectious diseases

Figure 17. Product Picture of Cancer

Figure 18. Product Picture of Protein quantitation

Figure 19. Product Picture of Other

Figure 20. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value Market Share by Application, 2023 & 2030

Figure 22. North America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value (2019-2030) & (US$ Million)

Figure 23. North America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Country (%), 2023 VS 2030

Figure 24. Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value (2019-2030) & (US$ Million)

Figure 25. Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Country (%), 2023 VS 2030

Figure 26. Asia Pacific Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value (2019-2030) & (US$ Million)

Figure 27. Asia Pacific Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Country (%), 2023 VS 2030

Figure 28. South America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value (2019-2030) & (US$ Million)

Figure 29. South America Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Country (%), 2023 VS 2030

Figure 30. Middle East & Africa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value (2019-2030) & (US$ Million)

Figure 31. Middle East & Africa Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Country (%), 2023 VS 2030

Figure 32. Key Countries/Regions Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value (%), (2019-2030)

Figure 33. United States Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, (2019-2030) & (US$ Million)

Figure 34. United States Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030

Figure 35. United States Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application (%), 2023 VS 2030

Figure 36. Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, (2019-2030) & (US$ Million)

Figure 37. Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030

Figure 38. Europe Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application (%), 2023 VS 2030

Figure 39. China Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, (2019-2030) & (US$ Million)

Figure 40. China Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030

Figure 41. China Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application (%), 2023 VS 2030

Figure 42. Japan Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, (2019-2030) & (US$ Million)

Figure 43. Japan Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030

Figure 44. Japan Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application (%), 2023 VS 2030

Figure 45. South Korea Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, (2019-2030) & (US$ Million)

Figure 46. South Korea Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030

Figure 47. South Korea Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application (%), 2023 VS 2030

Figure 48. Southeast Asia Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, (2019-2030) & (US$ Million)

Figure 49. Southeast Asia Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030

Figure 50. Southeast Asia Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application (%), 2023 VS 2030

Figure 51. India Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value, (2019-2030) & (US$ Million)

Figure 52. India Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Type (%), 2023 VS 2030

Figure 53. India Enzyme-Linked Immunosorbent Assay (Elisa) Testing Sales Value by Application (%), 2023 VS 2030

Figure 54. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Industrial Chain

Figure 55. Enzyme-Linked Immunosorbent Assay (Elisa) Testing Manufacturing Cost Structure

Figure 56. Channels of Distribution (Direct Sales, and Distribution)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions